Aurolab Trust Recalls FOCUS PI Hypromellose Due to Sterility Risk
Aurolab Trust recalls FOCUS PI Hypromellose 0.7% eye drops due to lack of sterility assurance. Check your batch numbers and expiration dates for affected units.
Stop using this now
Lack of Assurance of Sterility
What happened, in plain English
Aurolab Trust is recalling FOCUS PI Hypromellose 0.7% Formula eye drops because there is a lack of assurance that the product remains sterile. The recall affects 25,220 bottles distributed in Virginia. Because sterility cannot be guaranteed, using these drops could pose an infection risk to users. Read more at govinfonow.com/recall/1443829-aurolab-trust-recalls-focus-pi-hypromellose-0-7-formula-0.
Source Summary by GovInfoNow · govinfonow.com/recall/1443829-aurolab-trust-recalls-focus-pi-hypromellose-0-7-formula-0 · Updated October 13, 2026 · FDA enforcement record: FDA #D-0874-2026
Cite this page
“Aurolab Trust Recalls FOCUS PI Hypromellose Due to Sterility Risk.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/1443829-aurolab-trust-recalls-focus-pi-hypromellose-0-7-formula-0. Based on FDA recall #D-0874-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0874-2026%22&limit=1).
Why it’s dangerous
The primary hazard is a lack of assurance of sterility in the vials. If the solution is contaminated, introducing it into the eye can lead to serious infections or injury, particularly for those with compromised eye health.
Who’s affected
Consumers in Virginia who purchased FOCUS PI Hypromellose eye drops between the manufacturing date and the recall announcement on September 17, 2026. Individuals using these drops for dry eye relief or other ocular lubrication are at risk of potential infection if the product is not sterile.
How to tell if you have this one
Check your bottle for the NDC number 82724-007-19. Verify if you have either Batch# 6B093FI (Expiration 04/01/28) or Batch# 6F511F1 (Expiration 05/15/28). The product is labeled as STERILE and manufactured for Covalent Management, Inc. in Manassas, VA.
- Brand
Aurolab Trust- Category
Drug
What to do — step by step
Stop using the eye drops
Do not use any vials from the affected batches due to the sterility risk.
Check your batch numbers
Look at the label to see if you have Batch# 6B093FI or Batch# 6F511F1 with NDC 82724-007-19.
Contact the manufacturer
Reach out to Aurolab Trust or Covalent Management, Inc. for further instructions on disposal or return.
Where it went and when
Where it was distributed
Distributed in Virginia.
FDA distribution: “VA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Virginia.
Recall timeline
FDA published this recall 20 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Questions people ask
Why is this product being recalled?
The recall is due to a lack of assurance of sterility, meaning the product may not be free from harmful microorganisms.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0874-2026 (September 17, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0874-2026 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.